NCT00005793View on ClinicalTrials.gov

A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

July 31, 1999

Primary Completion Date

July 31, 2006

Study Completion Date

November 30, 2006

Conditions
Leukemia
Interventions
DRUG

Cytarabine

DRUG

Daunorubicin

DRUG

Etoposide

DRUG

Topotecan

Trial Locations (1)

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Sponsors

Collaborators (1)

SmithKline Beecham
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

SmithKline Beecham

INDUSTRY

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT00005793 - A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide | Biotech Hunter | Biotech Hunter